Monopar Therapeutics
MNPR
#7582
Rank
NZ$0.88 B
Marketcap
NZ$130.23
Share price
-0.94%
Change (1 day)
-3.20%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2026 (TTM): -NZ$31.04 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$24.82 Million, an increase over its 2024 earnings that were of -NZ$28.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$31.04 Million25.09%
2025 -NZ$24.82 Million-11.99%
2024 -NZ$28.2 Million85.5%
2023 -NZ$15.2 Million-20.1%
2022 -NZ$19.03 Million15.52%
2021 -NZ$16.47 Million44.39%
2020 -NZ$11.41 Million49.23%
2019 -NZ$7.65 Million28.04%
2018 -NZ$5.97 Million-80.07%
2017 -NZ$29.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 774.98%๐Ÿ‡บ๐Ÿ‡ธ USA